Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat. 1994

H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
Nephrology Section, Department of Veterans Affairs Medical Center, Miami, Florida 33125.

Previous studies from our laboratory have demonstrated impaired afferent arteriolar responsiveness to pressure in rats 4-6 weeks after the induction of diabetes mellitus. Although the responsible mechanisms mediating this renal autoregulatory defect have not been fully defined, increased polyol metabolism has been implicated as a possible factor involved in the pathogenesis of diabetic complications. We therefore investigated the possible role of this metabolic disturbance in renal autoregulation using the galactose-fed rat, a model characterized by increased polyol pathway activity independent of hyperglycemia or insulin deficiency. Hydronephrosis was induced to permit direct visualization of renal microvessels. Pressure-induced vasoconstriction of afferent arterioles was assessed by quantitating vessel diameter following stepwise increments of renal perfusion pressure (RAP; from 80 to 180 mm Hg) in the hydronephrotic kidneys from control rats and rats fed a 50% galactose diet for 2 or 4 weeks. Vessel diameters were measured from video images by computer-assisted image processing. Control rats exhibited progressive afferent arteriolar vasoconstriction when RAP was increased from 80 to 180 mm Hg (-17.3% +/- 1.0%; P < 0.001). In contrast, myogenic responses to increases in pressure were absent in the afferent arterioles of rats fed a 50% galactose diet for either 2 (-4.1% +/- 1.9%; not significant) or 4 weeks (-2.9 +/- 3.4%; not significant). Our demonstration that the impairment of afferent arteriolar responsiveness to increasing RAP in the normoglycemic galactose-fed rat was identical to that observed in the STZ-diabetic rat suggests that increased polyol accumulation may contribute to the impairment of renal autoregulation in the diabetic rat.

UI MeSH Term Description Entries
D007052 Ibuprofen A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties Advil,Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester,Brufen,Ibumetin,Ibuprofen, (+-)-Isomer,Ibuprofen, (R)-Isomer,Ibuprofen, (S)-Isomer,Ibuprofen, Aluminum Salt,Ibuprofen, Calcium Salt,Ibuprofen, Copper (2+) Salt,Ibuprofen, Magnesium Salt,Ibuprofen, Potassium Salt,Ibuprofen, Sodium Salt,Ibuprofen, Zinc Salt,Ibuprofen-Zinc,Motrin,Nuprin,Rufen,Salprofen,Trauma-Dolgit Gel,alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid,Ibuprofen Zinc,Trauma Dolgit Gel
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004376 Galactitol A naturally occurring product of plants obtained following reduction of GALACTOSE. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in GALACTOSEMIAS, a deficiency of GALACTOKINASE. Dulcitol

Related Publications

H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
August 1998, The Journal of physiology,
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
November 2008, American journal of physiology. Renal physiology,
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
June 1990, Hypertension (Dallas, Tex. : 1979),
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
December 1998, The American journal of physiology,
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
August 1998, The American journal of physiology,
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
November 2000, American journal of physiology. Renal physiology,
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
November 2000, British journal of pharmacology,
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
November 2008, American journal of physiology. Regulatory, integrative and comparative physiology,
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
July 1999, British journal of pharmacology,
H G Forster, and P M ter Wee, and T Takenaka, and T C Hohman, and M Epstein
August 1995, Investigative ophthalmology & visual science,
Copied contents to your clipboard!